Sector
Country
Publishers
Publication Date

All

Your search criteria

>> Country: Norway
1 - 10 of 1149
The Norwegian Radium Hospital Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile December-2016
From USD 250

The Norwegian Radium Hospital Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Industry Report

Summary The Norwegian Radium Hospital Research Foundation (RF) is a healthcare research hospital that offers clinical studies. The hospital conducts research programs and clinical studies. It provides services such as research and development. RF is a cancer research and rehabilitation center providing prevention and treatment. The hospital operates as a hub for cancer treatment and cancer research. It has established Oslo Cancer Cluster that is a development of new cancer diagnostics and me...

Download Sample Preview Sample
Vaccibody AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile December-2016
From USD 250

Vaccibody AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Industry Report

Summary Vaccibody AS (Vaccibody) is a pharmaceutical company that develops vaccines to treat and prevent cancer and infectious diseases. The company’s VB10.16 is a DNA based immunotherapy targeting malignancies caused by human papilloma virus 16. It is conducting an exploratory safety and immunogenicity study of HPV16+ immunotherapy VB10.16 in women with high grade intraepithelial neoplasia. Vaccibody offers vaccines against human papilloma virus induced cancer, melanoma, prostate cancer, B ...

Download Sample Preview Sample
Ultimovacs AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile December-2016
From USD 250

Ultimovacs AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Industry Report

Summary Ultimovacs AS (Ultimovacs) is a pharmaceutical company that develops novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapy such as surgery, chemotherapy, and irradiation. Ultimovacs’ product UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT), which is used for cancer treatment. The company performs three clinical trials w...

Download Sample Preview Sample
Nattopharma ASA (NATTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Nattopharma ASA (NATTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for bone and cardiovascular health. The company's MenaQ7 is a clinically-proven Vitamin K2 (MK-7) for bone and cardiovascular health. It develops products for supplement, health care and functional food markets. Nattopharma provides services such as marketing and sales support, clinical chemistry testing, and contract manufacturing services. The company also offers marketing and sales support...

Download Sample Preview Sample
Nextera AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Nextera AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Nextera AS (Nextera) is a drug discovery company that concentrates on high-resolution target discovery and lead candidate development in HLA class II associated mechanisms. The company offers various approaches to improve therapeutic intervention of disease classes including autoimmune diseases, cancer and chronic infections. It also concentrates on the discovery of autoimmune disease-specific antigens and develops new drugs and drug candidates for the treatment of autoimmune disease...

Download Sample Preview Sample
Nordic Nanovector ASA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Nordic Nanovector ASA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Nordic Nanovector ASA (Nordic Nanovector) formerly Nordic Nanovector AS, is a biotechnology company which develops and commercializes antibody radionuclide conjugates (ARC) for the treatment of haematological cancers. Its lead product candidate Betalutin, an antibody radionuclide conjugate designed for the treatment of non-Hodgkin Lymphoma (NHL), a life-threatening blood cancer. The company’s Betalutin consists of tumour-specific antibody HH1 which targets CD37 antigen on the surface...

Download Sample Preview Sample
Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Serodus ASA (SER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Serodus ASA (Serodus) is a drug development company that focused on the development of therapeutic products in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, which is intended for the treatment of diabetic nephropathy; SER140T2D, for type 2 diabetes; SER130AMI, for acute myocardial infarction; SER100PH, for pulmonary hypertension; and SER100TRISH, for therapy resistant isolated systolic hypertension. It acquires early stage drug ca...

Download Sample Preview Sample
Weifa ASA (WEIFA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Weifa ASA (WEIFA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering products for pain relief; treatment of cough and colds; dietary supplements; wound treatment; and treatments for osteoarthritis among others. Its research and development activities focus on prescr...

Download Sample Preview Sample
Genetic Analysis AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Genetic Analysis AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that offers technology services. The company develop, document and manufacture, marketing IVD products. It provides molecular diagnostics of diseases related to gut imbalances. It services include gut microbiota, patient testing and clinical research services. Genetic Analysis' technology utilizes common and variable DNA sequences within specified 16S rRNA gene of the bacteria to identify the different bacteria....

Download Sample Preview Sample
Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile November-2016
From USD 250

Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaceuticals and Healthcare Report in Norway

Company Report

Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. The company’s Medtech business unit launched a single use, digital urine meter under the brand name Sippi for patients in intensive care. Navamedic's Pharma and Healthcare business is a distributor of products from a number of drug manufacturers. Navamedic has distribution agreement with Aspen pharma, Sequenom Laboratories and Biotech Ph...

Download Sample Preview Sample
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved